Learn More
Medchemexpress LLC Olodanrigan | 1316755-16-4 | 98.9% | 100 MG

Supplier: Medchemexpress LLC HY13106100MG
Olodanrigan (EMA401) is a highly selective, orally active, and peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. This compound is currently under development as a therapeutic agent for neuropathic pain. Its analgesic action is attributed to the inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, which effectively inhibits both DRG neuron hyperexcitability and the sprouting of DRG neurons.
- Highly selective AT2 receptor antagonist
- Orally active and peripherally restricted
- A therapeutic agent candidate for neuropathic pain
- Inhibits p38 and p42/p44 MAPK activation
- Prevents DRG neuron hyperexcitability and sprouting
- Purity of 98.9%
- Store powder at -20°C for 3 years or 4°C for 2 years
- Store in solvent at -80°C for 2 years or -20°C for 1 year
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.